Dr Reddy's Laboratories share price rises 0.70% to ₹1,386.60 on November 12
Varda Khade
- 0 min read
Last Updated: 12th November 2026 - 06:58 pm
Key Takeaways
- Dr Reddy's Laboratories finished at ₹1,386.60, gaining ₹9.60 or 0.70%, and closed only ₹3.40 below the session high of ₹1,390.
- The close sat more than ₹118 above each supplied moving average, including the 200-day DMA of ₹1,247.60.
- Returns were positive across all measured periods, including 15.84% over one month, 15.07% over three months and 14.45% over one year.
Dr Reddy's Laboratories share price closed at ₹1,386.60 on November 12, gaining ₹9.60 or 0.70% from the previous close of ₹1,377. The stock opened at ₹1,377, matching that prior closing level, and then moved to a high of ₹1,390. Its session low was ₹1,372. The ₹18 range left the final price only ₹3.40 below the high and ₹14.60 above the low. Volume reached 1,246,962 shares.
The November 12 close was positioned substantially above the moving averages supplied for the stock. The 50-day DMA was ₹1,268.50, leaving a gap of ₹118.10. Dr Reddy's also finished ₹137.40 above the 100-day DMA of ₹1,249.20 and ₹139 above the 200-day DMA of ₹1,247.60. The 100-day and 200-day figures were separated by only ₹1.60.
Its annual range ran from ₹1,101 to ₹1,415. At ₹1,386.60, the stock was just ₹28.40 below the 52-week high and ₹285.60 above the low. The session high of ₹1,390 moved even closer to the annual peak, leaving a ₹25 difference. The closing price was also ₹9.60 above the opening level after beginning the day at the previous close.
Returns were positive across every period supplied by the source. Dr Reddy's recorded 15.84% over one month and 15.07% over three months. The six-month return stood at 8.34%, while the one-year result was 14.45%. The one- and three-month figures were closely matched, differing by just 0.77 percentage points, while the six-month number was the lowest of the four measured periods.
Frequently Asked Questions
What was Dr Reddy's Laboratories share price on November 12?
How close was Dr Reddy's to its 52-week high?
How did the stock compare with its 200-day DMA?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.